Baker Douglas P's Form 4 filing
OptimizeRx Corp (OPRX) · filed Aug 24, 2021
- Accession no.
- 0001213900-21-044609
- Filed
- Aug 24, 2021
- Trade date
- Aug 20-24, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $538.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baker Douglas PCIK 0001028775 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2021 | Common Stock (pursuant to 10B5-1 plan) | SSaleDisposed | −5,000 | $58.45 | −$292,250 | 58,796 | Direct | |
| Aug 24, 2021 | Common Stock (pursuant to 10B5-1 plan) | SSaleDisposed | −4,000 | $61.50 | −$246,000 | 54,796 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.